Teva completes acquisition of Allergan generics arm
Teva Pharmaceutical completes $40 billion acquisition of the generics arm of rival Allergan.
Tags
Allergan
News and updates about Allergan
Teva's $40.5 Billion deal expected to go through next week
Israeli pharmaceutical company wins regulatory approval for acquisition of Allergan, conditional upon giving up some of its products.
Israeli Pharma Giant Teva Buys Botox's Allergan
$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.
PreviousNext